Recently, Dr. Sun Yimin, President of CapitalBiotech, along with Dr. Li Yanze, Assistant President, visited Kyrgyzstan to hold a working meeting with officials from the Chinese Embassy in Kyrgyzstan. During the same period, at the 19th MedExpo Kyrgyzstan, Kanatbek Temirbekovich Bekboyev, Minister of Health of Kyrgyzstan, visited the CapitalBiotech’ booth and held in-depth discussions with Dr. Sun and his delegation, further advancing the construction of the Kyrgyzstan National Precision Medicine Center.
As the joint construction of the Belt and Road Initiative enters a new stage of high-quality development, CapitalBiotech is committed to seizing this opportunity and working closely with Kyrgyz partners to steadfastly promote high-quality cooperation under the BRI framework.
Major Benefits of Using Next Generation Sequencing PlatformsApril 2, 2026Next Generation Sequencing (NGS) platforms have revolutionized genomics by providing high-throughput, accurate, and cost-effective solutions for genetic research. These platforms have opened up new po...view
What Is The Most Accurate Alcohol Metabolism Test?March 11, 2024In the intricate domain of diagnostic testing, the quest for accuracy and reliability is perpetual. Among the myriad of tests, those aimed at deciphering alcohol metabolism stand out for their critica...view
What is In Vitro Diagnostic Reagents?April 4, 2023In vitro diagnostic reagents refer to in vitro diagnostic reagents managed by medical device management, including reagents, reagent kits, calibration products, quality control products, etc. used for...view
Is a Microarray Platform Right for Gene Expression?November 10, 2023When it comes to gene expression analysis, microarray platforms are a popular choice for researchers around the world. But is a microarray platform right for your specific needs? In this article, we w...view
Microarray Platforms with Various Applications in Genetic ResearchJuly 18, 2024In recent years, the advancements in genetic research have revolutionized our understanding of the human genome. At the forefront of these developments is the Microarray Platform, a pivotal technology...view